Delivery Order SPE2DB22D1017-SPE2DB24FF4CF
- Not listed
- This federal contract award, valued at $3,219.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of MULTAQ 400 MG TABLET 60S. The contract has a completion date of February 6, 2024 and is a firm fixed-price delivery order. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $6,992.30 for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2024 and is a Firm Fixed Price type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $6,980.50, is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 2, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award, valued at $20,498.44, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, and is a firm fixed-price delivery order with an ultimate completion date of January 29, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $22,557.90 firm fixed-price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 22, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of MULTAQ 400 MG TABLET 60S. The $5,798.82 firm-fixed-price delivery order has an ultimate completion date of September 28, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award, valued at $2,806.20, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a final completion date of March 6, 2023. The contract is a firm-fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,848.46 firm fixed-price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of March 12, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides medical products and supplies to federal government agencies, including the military and veterans' healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $8,030.70 firm fixed-price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The...
- This federal contract award, valued at $25,533.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the provision of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an Ultimate Completion Date of May 7, 2024 and a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF4CFDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price type, valued at $7,417.27, for the supply of the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 3/12/24 |